Zimmer Biomet Holdings Inc. (ZBH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Zimmer Biomet Holdings Inc. (ZBH) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How ZBH Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $8.23B | 69.7% | 13.3% | $705.1M | $1.47B | 4.6% |
| FY 2024 | $7.68B | 71.5% | 16.7% | $903.8M | $1.30B | 5.9% |
| FY 2023 | $7.39B | 44% | 17.3% | $1.02B | $1.25B | 16.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring ZBH)
- ✓Live walkthrough of ZBH's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
ZBH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +7.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ZBH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ZBH. Explore sector supply chains on /butterfly.
ZBH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Zimmer Biomet Holdings Inc. (ZBH)?
In FY 2025 (10-K), ZBH converted $8.2B of revenue into a 69.7% gross margin, 13.3% operating margin, and $1.5B in free cash flow (17.9% FCF margin).